Wednesday, November 11, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· February 2, 2026

The Walt Disney Company Reports First Quarter Earnings for Fiscal 2026

View original at finance.yahoo.com
“On track to repurchase $7 billion of stock”
Verbatim excerpt from the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Experiences segment operating income will show high-single digit growth for full year FY2026, weighted to second half

    80% confidence
  • Cash from operations will be $19B for full year FY2026

    80% confidence
  • Entertainment segment operating income will be comparable to Q2 FY2025 in Q2 FY2026

    80% confidence
  • Entertainment segment operating income will show double-digit growth for full year FY2026, weighted to second half

    80% confidence
  • SVOD operating margin will reach 10% for full year FY2026

    80% confidence
  • Sports segment operating income will decline by $100M in Q2 FY2026

    80% confidence
  • Disney delivered strong box office performance in calendar year 2025 with billion-dollar hits like Zootopia 2 and Avatar: Fire and Ash, franchises that generate value across many of Disney's businesses

    80% confidence
  • Adjusted EPS will show double-digit growth for full year FY2026

    80% confidence
  • CEO is incredibly proud of all that Disney has accomplished over the past three years

    80% confidence
  • Disney is pleased with the start to fiscal year 2026 and achievements reflect tremendous progress made

    80% confidence
  • SVOD operating income will be approximately $500M in Q2 FY2026, representing $200M increase over Q2 FY2025

    80% confidence
  • Disney is on track with $7B stock repurchase program for FY2026

    80% confidence
  • Sports segment operating income will show low-single digit growth for full year FY2026

    80% confidence

Data points we hold from this source

The Walt Disney Company · corporate expenses304000000 USD
The Walt Disney Company · current borrowings10800000000 USD
The Walt Disney Company · depreciation1000000000 USD
The Walt Disney Company · diluted eps1.40 USD
The Walt Disney Company · domestic parks capex2300000000 USD
The Walt Disney Company · entertainment capex293000000 USD
The Walt Disney Company · long term debt35800000000 USD
The Walt Disney Company · treasury stock9500000000 USD
The Walt Disney Company · interest expense net275000000 USD
The Walt Disney Company · income before taxes3700000000 USD
The Walt Disney Company · international parks capex357000000 USD
The Walt Disney Company · total equity114000000000 USD
The Walt Disney Company · receivables15100000000 USD
The Walt Disney Company · capital expenditures3000000000 USD
The Walt Disney Company · total assets202100000000 USD
The Walt Disney Company · cash from operations735000000 USD
The Walt Disney Company · tax rate32.7 percent
The Walt Disney Company · segment operating income5100000000 USD
The Walt Disney Company · adjusted eps1.76 USD
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Biotech Catalyst Wave: Late-2026 Clinical Readouts, PDUFA Dates and Capital Restructuring
A dense cluster of Q4 2026 to Q1 2027 clinical and regulatory catalysts spans hepatitis delta (Vir's ECLIPSE/SOLSTICE), hypertension and sleep apnea (Mineralys' lorundrostat, PDUFA 2026-12-22), severe hypertriglyceridemia (plozasiran), oncology (ivonescimab BLA, PDUFA 2026-11-14) and gene therapy (Krystal). Positive data flow from AASLD and AHA presentations is offset by cost-cutting guidance, milestones slipping into 2027, and a delisting process that signals capital-market stress for some issuers. Near-term value hinges on binary FDA decisions and Phase 3 topline readouts in Q1 2027.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,564 source documents archived
Query this data → isubstrate.com
The Walt Disney Company Reports First Quarter Earnings for Fiscal 2026 — Source | Via News | Via News